Skip to main content
Premium Trial:

Request an Annual Quote

GenVault Nabs $18M in VC Cash; Funds Will Help Commercialize Biosample Tech

This article has been updated from a previous version, which omitted the fact that Domain Associates also participated in the current funding round.
NEW YORK (GenomeWeb News) — GenVault today said it has secured $18 million in financing from Domain Associates and QuestMark Partners, a new investor.  
As a result, Benjamin Schapiro, a partner at QuestMark, will join GenVault’s board of directors.
GenVault makes a dry-state platform that extracts, preserves, recovers, and distributes biosamples. GenVault said it plans to use the cash to help it commercialize the platform.
QuestMark focuses its investing on “late-stage growth companies in emerging markets,” GenVault said.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.